Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1994 Dec;220(6):775–781. doi: 10.1097/00000658-199412000-00011

Clinical implications of cervical lymph node metastasis patterns in thoracic esophageal cancer.

T Nishimaki 1, O Tanaka 1, T Suzuki 1, K Aizawa 1, K Hatakeyama 1, T Muto 1
PMCID: PMC1234480  PMID: 7986145

Abstract

OBJECTIVE. The authors attempt to clarify the clinical implications of cervical lymph node metastases from thoracic esophageal cancers. SUMMARY BACKGROUND DATA. Cervical lymph node metastases from thoracic esophageal cancer have been considered to be incompatible with curative resection. However, recent studies have demonstrated that cure is achievable in patients with such metastases. METHODS. Patterns of esophageal cancer metastasis to the cervical nodes and long-term results after tumor resection were investigated in 23 patients undergoing bilateral cervical lymphadenectomy for treatment of thoracic esophageal cancer. RESULTS. The number of positive nodes per patient was significantly greater (p < 0.05) in lower esophageal cancers (median: 15) than in upper or mid esophageal cancers (median: 2.5). Simultaneous metastases to three nodal regions (the neck, mediastinum, and abdomen) were significantly more common (p < 0.001) in lower esophageal tumors (88.9%) than in upper and mid esophageal lesions (7.1%). Although the overall 5-year survival rate was 16.5%, long-term survival was achieved only in patients with upper or mid esophageal cancer.

Full text

PDF
775

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Inatsu K. [Experimental and clinical studies on the lymph flow of the esophagus--with special reference to the extra-mural lymph flow]. Igaku Kenkyu. 1984 May;54(5):535–556. [PubMed] [Google Scholar]
  2. Isono K., Sato H., Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology. 1991;48(5):411–420. doi: 10.1159/000226971. [DOI] [PubMed] [Google Scholar]
  3. Japanese Society for Esophageal Diseases Guide lines for the clinical and pathologic studies on carcinoma of the esophagus. Jpn J Surg. 1976 Jun;6(2):69–78. doi: 10.1007/BF02468889. [DOI] [PubMed] [Google Scholar]
  4. Kato H., Tachimori Y., Watanabe H., Iizuka T., Terui S., Itabashi M., Hirota T. Lymph node metastasis in thoracic esophageal carcinoma. J Surg Oncol. 1991 Oct;48(2):106–111. doi: 10.1002/jso.2930480207. [DOI] [PubMed] [Google Scholar]
  5. Koike T., Hirono T., Yamaguchi A., Takizawa T., Yamato Y., Sohma T., Yoshiya K., Eguchi S. [Scalene node biopsy in resectable primary lung cancer]. Nihon Kyobu Geka Gakkai Zasshi. 1988 Jun;36(6):870–873. [PubMed] [Google Scholar]
  6. Nishimaki T., Tanaka O., Suzuki T., Aizawa K., Watanabe H., Muto T. Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment. World J Surg. 1993 Nov-Dec;17(6):766–772. doi: 10.1007/BF01659091. [DOI] [PubMed] [Google Scholar]
  7. Sannohe Y., Hiratsuka R., Doki K. Lymph node metastases in cancer of the thoracic esophagus. Am J Surg. 1981 Feb;141(2):216–218. doi: 10.1016/0002-9610(81)90160-4. [DOI] [PubMed] [Google Scholar]
  8. Skinner D. B., Little A. G., Ferguson M. K., Soriano A., Staszak V. M. Selection of operation for esophageal cancer based on staging. Ann Surg. 1986 Oct;204(4):391–401. doi: 10.1097/00000658-198610000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES